Torque’s Torcort M8 Tablets contain methylprednisolone, which is a glucocorticoid. It exhibits anti-inflammatory and immunosuppressive properties.
Pharmaceutical Dosage Form:
Tablet
Route of Administration:
Oral
Composition:
Each uncoated dispersible tablet contains:
- Methylprednisolone 8 mg
- Excipients q.s.
Mechanism of Action:
Methylprednisolone is used for its anti- inflammatory effects in disorders of many organ systems. It acts in various ways to decrease the inflammatory cycle, including dampening the inflammatory cytokine cascade, inhibiting the activation of T cells, decreasing the extravasation of immune cells into the central nervous system, facilitating the apoptosis of activated immune cells, and indirectly decreasing the cytotoxic effects of nitric oxide and tumor necrosis factor alpha.
Indications:
Torque’s Torcort M8 Tablets are indicated for severe allergic, dermatologic, endocrine, gastrointestinal, hematologic, neoplastic, nervous system, ophthalmic, renal, respiratory, rheumatic disorders unresponsive to conventional treatments, localized inflammatory or hypertrophic lesions (e.g., alopecia areata, keloids, psoriatic plaques, ganglia). acute and chronic joint or soft tissue inflammatory conditions (e.g., arthritis, bursitis, tenosynovitis).
Dosage:
As directed by the physician.
Storage:
Store in a dry place at a temperature not exceeding 30°C. Protect from light.
Presentation:
10 X 10 Tablets
Side effects:
Abdominal distention, Muscle weakness, Loss of muscle mass, Osteoporosis, Hypertension, Fluid retention, Potassium loss.
Contraindications:
Torque’s Torcort 8 Tablets are contraindicated in patients with a known allergy to constituents or excipients, during pregnancy and lactation, and in patients with severe hepatic failure or renal impairment.
Drug Interactions:
Torque’s Torcort M8 Tablets can cause drug interactions with the following drugs: Oral Anticoagulants, Cyclosporine, Phenobarbital, Phenytoin, Rifampin, Aspirin, Ketoconazole.
